NCT04413396

Brief Summary

Many infectious diseases require a therapy that is administered intravenously due to a lack of oral treatments. Affected patients often have to stay weeks or even months in hospital just for receiving their therapy although they do not feel severely unwell. Outpatient parenteral antibiotic therapy (OPAT) allows these patients under certain requirements to get discharged from hospital and apply the antibiotic treatment on their own. For these patients quality of life improves by feeling more comfortable at home and being able to participate in everyday life or even go back to work. For the hospitals a reduced inpatient health care means a clear reduction of costs. The aim of OPATReg is to examine under which conditions the OPAT can be established at different locations of patient care. For this purpose, patients with APAT are to be treated and data collected at 7 university institutions in Germany. All centers have the expertise to provide comprehensive care for patients with infectious diseases, to transfer them from inpatient to outpatient care and to continue to provide care there. If successful, the project should help to identify the potential of OPAT for all of Germany. If positive effects and feasibility can be demonstrated OPAT could become an important therapy option with many advantages for certain patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 2, 2020

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

November 5, 2020

Status Verified

November 1, 2020

Enrollment Period

3.7 years

First QC Date

May 28, 2020

Last Update Submit

November 3, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Number of Patients with effective OPAT

    Successful administration and completion of the antiinfective therapy

    12 weeks

  • Number of Patients With Treatment-Related Adverse Events

    side-effects of treatment and catheter-related infections

    12 weeks

  • Number of Hospitals being able to apply OPAT

    Feasibility of OPAT under differing hospital specific circumstances

    12 weeks

Study Arms (1)

Outpatient parenteral antimicrobial therapy

Patients with an infectious disease that receive an outpatient parenteral antimicrobial therapy

Procedure: Outpatient Parenteral Antibiotic Therapy

Interventions

Application of outpatient parenteral antibiotic therapy in patients with infectious diseases to allow them to get discharged from hospital.

Outpatient parenteral antimicrobial therapy

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults getting OPAT in one of the participating study sites

You may qualify if:

  • patients who get OPAT

You may not qualify if:

  • patients who don't get OPAT

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Cologne

Cologne, 50937, Germany

RECRUITING

Study Officials

  • Clara Lehmann, Prof.

    Head of Outpatient Department in ID, University Hospital of Cologne

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
6 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of outpatient clinic

Study Record Dates

First Submitted

May 28, 2020

First Posted

June 2, 2020

Study Start

October 1, 2019

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

November 5, 2020

Record last verified: 2020-11

Locations